false
OasisLMS
Catalog
Evolving Trends in Skull Base Tumor Management
Evolving Trends in Skull Base Tumor Management
Evolving Trends in Skull Base Tumor Management
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The session was focused on various topics relating to skull base tumors and the role of social and molecular factors in surgery outcomes. Discussions ranged from the use of laser ablation (LIT) in treating recurrent meningiomas, particularly highlighting its minimal invasive nature and the potential complications when identifying cranial nerves during procedures, to molecular markers and targeted therapies for tumors like chordomas, meningiomas, and vestibular schwannomas. The speakers showcased advances in understanding the role of molecular signatures and methylation in predicting tumor behavior and response to treatments. Dr. Zadeh emphasized the need for precise molecular classifications to better guide therapeutic approaches, potentially surpassing WHO grading systems in the future. Data from tumor resection surgeries and social capital's impact on post-surgery outcomes were shared. The presentations stressed the significance of social connectedness, with findings suggesting that strong community support networks can influence surgical recovery and discharge processes. Additionally, there was a focus on assessing viral reactivation's involvement and antiviral therapy in managing delayed facial palsy post vestibular schwannoma resection. Despite the varied approaches, the theme underscored the importance of integrating novel scientific insights with clinical practices to enhance surgical outcomes and patient care.
Keywords
skull base tumors
social factors
molecular factors
laser ablation
recurrent meningiomas
molecular markers
targeted therapies
molecular signatures
tumor behavior
surgical outcomes
social connectedness
viral reactivation
×
Please select your language
1
English